Stock screener

OCUL

Conviction 38HealthcareScan · Mon, Aug 10, 2026
OCUL$9.25+0.65%
ResistanceSupportVol 14Insider sell
63 bars
4
Vol MA14 2.16M
May 11May 28Jun 16Jul 6Jul 23Aug 10
OCULAR THERAPEUTIX, INCPHARMACEUTICAL PREPARATIONSwww.ocutx.com
Price9.25
Change+0.65%
Gap-0.22%
Rel volume2.09×
Avg volume2.08M
Avg $ vol18.29M
SMA 208.80
SMA 509.14
SMA 20010.01
Price vs 50+1.25%
Price vs 200-7.59%
MA stackmixed
50/200 cross
Supertrenddown · 9.60
RSI (14)55
MACD hist0.08
MACD crossbull · 1d
Stoch %K / %D96 / 85
ADX (14)17
+DI / −DI22 / 16
RSI divergence
MACD divergence
ATR %+4.55%
ADR %4.59%
52w high16.11
52w low6.88
From 52w high-42.58%
Above 52w low+34.45%
New 52w highNo
SqueezeOff
Bollinger width20.36%
%B0.75
Donchian pos58.05%
Donchian high10.05
Donchian low8.15
AVWAP (52w high)9.68
vs AVWAP high-4.44%
AVWAP (52w low)8.80
vs AVWAP low+5.17%
OBV trendFlat
Chaikin MF (20)0.00
Today vs 20d2.09×
Avg vol (14d)2.16M
Avg vol (20d)2.08M
Avg $ vol (20d)18.29M
Market cap2.03B
RS 3m (vs SPY)-10.76%
RS 6m (vs SPY)-10.97%
RS line new highNo
Trend template2/8
Technical rank35.0
1 week+10.12%
1 month-9.31%
3 months-4.15%
6 months+0.98%
1 year-24.80%
YTD-21.74%
P/E-7.64
P/B3.91
P/S39.10
P/FCF-9.37
EPS-1.42
Div yield
ROE-51.14%
ROA-39.61%
Debt/Eq0.03
Current13.11
EV/EBITDA-5.46
Gross margin
Net margin-511.90%
Rev growth-18.47%
EPS growth-37.43%
Price target25.78
Target upside178.70%
Analyst ratingBuy
Institutional101.10%
Ent. value1.45B
Revenue13.47M
Net income-78.76M
Gross profit
Free cash flow-216.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out218.96M
Employees325
ListedFri, Jul 25, 2014
Free float179.1M
Float %82.3%
Short interest27.03M
Days to cover13.1d
Short volume63.3%
Squeeze score86 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.35 vs −$0.40
Last surprise+12.5% beat
Setup gradeD
Conviction38 / 100
Pattern quality
Tech rank35.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance10.78
Support8.24
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OCUL

All disclosures →
No recent disclosed trades by Congress in OCUL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OCUL · 3 buys · 7 sells

InsiderSideShares
Dugel Pravin
See Remarks · Common Stock · 2026-06-16
Gift50.09K
Dugel Pravin
See Remarks · Common Stock · 2026-06-16
Gift50.09K
Waheed Nadia
Chief Medical Officer · Common Stock · 2026-06-03
Sell14.83K
Dugel Pravin
See Remarks · Common Stock · 2026-05-28
Gift394.7K
Dugel Pravin
See Remarks · Common Stock · 2026-05-28
Gift394.7K
Dugel Pravin
See Remarks · Common Stock · 2026-05-26
Sell21.16K
Kaiser Peter
Chief Development Officer · Common Stock · 2026-05-26
Sell2.97K
Heier Jeffrey S.
Chief Scientific Officer · Common Stock · 2026-05-26
Sell3.02K
Nayak Sanjay
Chief Strategy Officer · Common Stock · 2026-05-26
Sell1.86K
Dugel Pravin
See Remarks · Common Stock · 2026-04-09
Gift394.7K

SEC filings

EDGAR filings in OCUL · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.